Henry H. Armstrong Associates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Hold
3,489
0.02% 60
2026
Q1
$248K Hold
3,489
0.03% 54
2025
Q4
$286K Hold
3,489
0.03% 54
2025
Q3
$262K Hold
3,489
0.02% 54
2025
Q2
$258K Hold
3,489
0.02% 52
2025
Q1
$282K Hold
3,489
0.03% 54
2024
Q4
$273K Sell
3,489
-153
-4% -$13K 0.03% 53
2024
Q3
$342K Sell
3,642
-32
-0.9% -$2.69K 0.03% 55
2024
Q2
$286K Sell
3,674
-125
-3% -$10.2K 0.03% 54
2024
Q1
$345K Sell
3,799
-240
-6% -$20K 0.03% 48
2023
Q4
$312K Sell
4,039
-66
-2% -$4.62K 0.03% 48
2023
Q3
$279K Buy
4,105
+153
+4% +$11.1K 0.03% 50
2023
Q2
$321K Sell
3,952
-484
-11% -$38.6K 0.04% 48
2023
Q1
$364K Buy
+4,436
New +$317K 0.04% 47

Other funds holding GEHC

Henry H. Armstrong Associates's GEHC Position: Q2 2026 in Review

Henry H. Armstrong Associates held its GE HealthCare (GEHC) position steady in Q2 2026 at 3,489 shares worth $223K. The position accounts for 0.02% of the portfolio, ranked #60.

Henry H. Armstrong Associates first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $364K in Q1 2023. 502 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Henry H. Armstrong Associates held 3,489 shares of GE HealthCare worth $223K as of Q2 2026.
  • Henry H. Armstrong Associates left its GE HealthCare share count unchanged in Q2 2026.
  • GE HealthCare made up 0.02% of Henry H. Armstrong Associates's portfolio in Q2 2026, its #60 holding.
  • Henry H. Armstrong Associates first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Henry H. Armstrong Associates's GE HealthCare position peaked at $364K in Q1 2023.
  • 502 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Henry H. Armstrong Associates's 13F filing for Q2 2026, filed 7 Jul 2026.